Breaking News Instant updates and real-time market news.

VSAR

Versartis

$21.60

-0.25 (-1.14%)

17:00
09/21/17
09/21
17:00
09/21/17
17:00

Versartis trading resumes

VSAR Versartis
$21.60

-0.25 (-1.14%)

09/08/17
PIPR
09/08/17
NO CHANGE
Target $26
PIPR
Overweight
Piper says own Versartis into Phase III data later this month
Piper Jaffray analyst Edward Tenthoff recommends owning shares of Versartis into the Phase III Velocity data on somavaratan in pediatric growth hormone deficiency due by the end of September. The analyst continues to expect somavaratan to demonstrate non-inferior height velocity within the 2cm lower confidence interval to daily growth hormone at one year. Even if somavaratan produces numerically lower height velocity to daily growth hormone, this would be a win since less frequent dosing should result in higher real-world compliance and growth, Tenthoff tells investors in a research note. He reiterates an Overweight rating on Versartis with a $26 price target.
09/01/17
LEER
09/01/17
NO CHANGE
Target $28
LEER
Market Perform
Ascendis shares could move 20% on Versartis data, says Leerink
Leerink analyst Joseph Schwartz believes shares of Ascendis Pharma (ASND) could move up or down 20% on Versartis' (VSAR) somavaratan data in September. The data may have important read-through for Ascendis since it may indicate how much of the long-acting growth hormone market TransCon hGH will need to compete for. The analyst notes his base case scenario has Ascendis shares remaining flat or trading slightly down on somavaratan efficacy, which is "noninferior to daily Genotropin and safety which is acceptable." Schwartz reiterates a Market Perform rating on Ascendis with a $28 price target.
06/27/17
PIPR
06/27/17
NO CHANGE
Target $26
PIPR
Overweight
Piper a buyer of Versartis ahead of September data
Piper Jaffray analyst Edward Tenthoff says he's a buyer of Versartis shares ahead of the Phase III Velocity data on somavartan in pediatric growth hormone deficiency expected in September. The analyst is "confident" somavaratan will meet the primary endpoint of non-inferior height velocity at 12 months based on Phase II Vista data that showed consistent HV out to three years. He reiterates an Overweight rating on the shares with a $26 price target.
05/05/17
05/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Buy at Cleveland Research. 2. Versartis (VSAR) initiated with an Overweight at Cantor. 3. Alder Biopharmaceuticals (ALDR) initiated with a Sell at UBS. 4. Playa Hotels & Resorts (PLYA) initiated with a Neutral at Citi. 5. Coherus Biosciences (CHRS) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

XLB

S&P Select Materials SPDR

$60.48

-0.22 (-0.36%)

08:19
02/20/18
02/20
08:19
02/20/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$2.96

0.024 (0.82%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Upgrade
Bombardier rating change  »

Bombardier upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$50.12

0.44 (0.89%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLNT

Planet Fitness

$32.38

-0.05 (-0.15%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Recommendations
Planet Fitness analyst commentary  »

Planet Fitness price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

XLP

Consumer Staples Sector SPDR

$55.60

0.22 (0.40%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$85.41

0.61 (0.72%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAH

Cardinal Health

$69.34

1.24 (1.82%)

08:18
02/20/18
02/20
08:18
02/20/18
08:18
Periodicals
Cardinal accused by Kentucky AG of contributing to opioid epidemic, Reuters says »

Cardinal Health has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

STLD

Steel Dynamics

$49.40

2.26 (4.79%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Hot Stocks
Steel Dynamics raises dividend 21% to 18.75c »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$153.34

0.54 (0.35%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLNO

Soleno Therapeutics

$1.62

-0.11 (-6.36%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Hot Stocks
Soleno Therapeutics announces successful end-of-Phase II meeting with FDA »

Soleno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$251.96

0.11 (0.04%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$53.83

0.08 (0.15%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Technical Take: HSBC falls after results »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

SPY

SPDR S&P 500 ETF Trust

$273.11

0.08 (0.03%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$28.98

-0.04 (-0.14%)

08:17
02/20/18
02/20
08:17
02/20/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$23.93

-0.58 (-2.37%)

08:16
02/20/18
02/20
08:16
02/20/18
08:16
Hot Stocks
PTC Therapeutics: FDA's OND denies PTC's appeal of CRL on NDA for ataluren »

PTC Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

SMH

Market Vectors Semiconductor

$102.79

-0.22 (-0.21%)

08:16
02/20/18
02/20
08:16
02/20/18
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERI

Eldorado Resorts

$33.55

1.1 (3.39%)

08:16
02/20/18
02/20
08:16
02/20/18
08:16
Initiation
Eldorado Resorts initiated  »

Eldorado Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

DIN

DineEquity

$54.67

-0.29 (-0.53%)

08:15
02/20/18
02/20
08:15
02/20/18
08:15
Conference/Events
DineEquity to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 26

    Feb

08:15
02/20/18
02/20
08:15
02/20/18
08:15
General news
Canada wholesale trade preview »

Canada wholesale trade…

HD

Home Depot

$186.97

1.7 (0.92%)

08:15
02/20/18
02/20
08:15
02/20/18
08:15
Recommendations
Home Depot analyst commentary  »

Home Depot weakness would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

FOX

21st Century Fox

$37.04

0.39 (1.06%)

, FOXA

21st Century Fox

$37.46

0.5 (1.35%)

08:14
02/20/18
02/20
08:14
02/20/18
08:14
Periodicals
Fox extends Sky News guarantee to secure bid approval, Reuters reports »

Rupert Murdoch's…

FOX

21st Century Fox

$37.04

0.39 (1.06%)

FOXA

21st Century Fox

$37.46

0.5 (1.35%)

SKYAY

Sky

$61.77

0.025 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 01

    Mar

  • 05

    Mar

MDT

Medtronic

$83.31

0.37 (0.45%)

08:14
02/20/18
02/20
08:14
02/20/18
08:14
Hot Stocks
Medtronic says making progress towards surgical robotics platform launch »

Says saw mid-single digit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 14

    Mar

  • 23

    Mar

TSCO

Tractor Supply

$67.32

-1.82 (-2.63%)

08:13
02/20/18
02/20
08:13
02/20/18
08:13
Conference/Events
Tractor Supply to hold a meeting »

2018 Investment Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

DRIO

DarioHealth

$1.46

-0.03 (-2.01%)

, AMZN

Amazon.com

$1,448.69

-13.07 (-0.89%)

08:12
02/20/18
02/20
08:12
02/20/18
08:12
Hot Stocks
DarioHealth to sell Dario Blood Glucose Monitoring System on Amazon.com »

DarioHealth (DRIO)…

DRIO

DarioHealth

$1.46

-0.03 (-2.01%)

AMZN

Amazon.com

$1,448.69

-13.07 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 18

    Mar

PRGO

Perrigo

$89.55

-0.1 (-0.11%)

08:12
02/20/18
02/20
08:12
02/20/18
08:12
Hot Stocks
Perrigo names Ronald Winowiecki as CFO »

Perrigo announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.